Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts. Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts.](/p.php?pid=staticchart&s=N%5EONXX&p=8&t=15)
ONYX Pharmaceuticals to Present at Upcoming Conferences
RICHMOND, Calif., April 19 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. today
announced that it will present at three investment conferences in April and
May.
The Second Annual White Mountain Capital Biotechnology Conference:
The first presentation will be at The Second Annual White Mountain Capital
Biotechnology Conference in New York City, New York, on Thursday, April 22, at
10:10 a.m. Eastern Time. Interested parties may access a live webcast of the
presentation at:
http://www.corporate-/
ir.net/ireye/ir_site.zhtml?ticker=ONXX&script=1010&item_id=873054
Morgan Stanley Global Healthcare Unplugged Conference:
Subsequently, Onyx will present at the Morgan Stanley Global Healthcare
Unplugged Conference in Miami, Florida, on Wednesday, May 5 at 11:15 a.m.
Eastern Time. Interested parties may access a live webcast of the presentation
at:
http://customer.talkpoint.com/MORG007/050504a_cf/default.asp?entity=onyx
SunTrust Robinson Humphrey Therapeutics Conference:
Finally, Onyx will present at the SunTrust Robinson Humphrey Therapeutics
Conference in New York City, New York on Tuesday, May 11 at 9:30 a.m. Eastern
Time. Interested parties may access a live webcast of the presentation at:
https://www.suntrustrh.com/ConferencesEvents/conferencedetails.asp?cid=10
It is recommended that viewers log on 15 minutes early in order to register and
download any necessary software. If you are unable to participate during
either of the live webcasts, a recorded replay of the presentations will be
available within 24 hours of the completion of the presentations. The replays
will generally remain available for one month following the presentation dates.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies
that target the molecular basis of cancer. With its partners, the company is
developing small molecule drugs, including BAY 43-9006 with Bayer
Pharmaceuticals Corporation. For more information about Onyx's pipeline and
activities, visit the company's web site at http://www.onyx-pharm.com/.
DATASOURCE: Onyx Pharmaceuticals, Inc.
CONTACT: Julie Wood of Onyx Pharmaceuticals, Inc., +1-510-262-8757
Web site: http://www.onyx-pharm.com/